Aug 4 (Reuters)-
Oncolys Biopharma Inc.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Jun 30, 2017 Jun 30, 2016 Dec 31, 2017
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 19 mln 44 mln 200 mln
(-55.5 pct) (+464.9 pct) (+112.4 pct)
Operating loss 509 mln loss 410 mln loss 1.40
Recurring loss 517 mln loss 416 mln loss 1.40
Net loss 518 mln loss 417 mln loss 1.40
EPS loss 53.89 yen loss 45.51 yen loss 152.08 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Oncolys Biopharma Inc..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4588.T
((Tokyo Headline News Desk +813 6441 1812))